New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
April 14, 2014
10:02 EDTWFM, STM, OSK, MIICF, MPO, MSFT, MDT, JNJ, HTWR, ENB, OFC, GLW, BEP, CIB, ANFGYOn The Fly: Analyst Downgrade Summary
Antofagasta (ANFGY) downgraded to Hold from Buy at Canaccord... Bancolombia (CIB) downgraded to Neutral from Overweight at JPMorgan... Brookfield Renewable (BEP) downgraded to Neutral from Outperform at Credit Suisse... Corning (GLW) downgraded to Hold from Buy at Stifel... Corporate Office Properties (OFC) downgraded to Neutral from Buy at ISI Group... Enbridge (ENB) downgraded to Neutral from Outperform at Credit Suisse... HeartWare (HTWR) downgraded to Sell from Neutral at Goldman... Johnson & Johnson (JNJ) downgraded to Hold from Buy at Jefferies... Medtronic (MDT) downgraded to Neutral from Overweight at JPMorgan... Microsoft (MSFT) downgraded to Hold from Buy at Deutsche Bank... Midstates Petroleum (MPO) downgraded to Hold from Buy at MLV & Co... Millicom (MIICF) downgraded to Sell from Hold at Berenberg... Oshkosh (OSK) downgraded to Accumulate from Buy at Global Hunter... STMicroelectronics (STM) downgraded to Sell from Neutral at UBS... Whole Foods (WFM) downgraded to Hold from Buy at BB&T...
News For ANFGY;CIB;BEP;GLW;OFC;ENB;HTWR;JNJ;MDT;MSFT;MPO;MIICF;OSK;STM;WFM From The Last 14 Days
Check below for free stories on ANFGY;CIB;BEP;GLW;OFC;ENB;HTWR;JNJ;MDT;MSFT;MPO;MIICF;OSK;STM;WFM the last two weeks.
Sign up for a free trial to see the rest of the stories you've been missing.
1 | 2 | 3 | 4 | 5 | all recent news | >>
September 17, 2014
07:43 EDTMDTBofA/Merrill to hold a conference
Subscribe for More Information
06:39 EDTMSFTMicrosoft planning new wave of layoffs for this week, ZDNet reports
Subscribe for More Information
06:09 EDTMDTIntegra LifeSciences to acquire Medtronic instrumentation lines for $60M
Integra LifeSciences (IART) and Medtronic (MDT) announced an agreement in which Integra will acquire Medtronic's MicroFrance and Xomed manual ENT and laparoscopy instrumentation lines for approximately $60M in cash. Integra expects the transaction to close in Q4. Integra will acquire a portfolio of approximately 4,000 MicroFrance and Xomed manual ENT and laparoscopic surgical instruments, as well as the St. Aubin le Monial, France manufacturing facility. Sales from the products being acquired totaled approximately $30M, two-thirds of which were generated outside the U.S. Integra expects to record approximately $27M-$30M in revenue and approximately 10c of adjusted EPS in calendar 2015 from this acquisition. The earnings accretion should rise after the first year once certain sales transitions are complete. The company expects the acquisition to contribute less than $5M in revenue and be neutral to earnings in Q4. The transition and integration is expected to be completed by 2H15.
September 16, 2014
19:18 EDTMSFTMicrosoft to add Kraft CFO Teri List-Stoll, Visa CEO Charles Scharf to board
Subscribe for More Information
19:16 EDTMSFTMicrosoft raises dividend 11% to 31c per share
Subscribe for More Information
18:59 EDTMSFTMicrosoft to add Kraft CFO List-Stoll, Visa CEO Scharf to board, Bloomberg says
Microsoft board members Marquardt and Dublon are retiring from the board, according to Bloomberg, citing an emailed press release from the company.
18:54 EDTMSFTMicrosoft raises dividend 11% to 31c per share, Bloomberg says
Subscribe for More Information
14:02 EDTMSFTMicrosoft volatility flat, shares near fresh 14-year high
Subscribe for More Information
11:51 EDTMDTOECD looks to close tax loopholes with new proposals
Subscribe for More Information
10:37 EDTMSFTMicrosoft weighs German-only cloud platform, Datacenter Dynamics reports
Subscribe for More Information
10:01 EDTOFCBofA/Merrill REITs analysts hold an analyst/industry conference call
CMBS Strategist Todd, U.S. REIT Analyst Spector, REIT Fixed Income Analyst Frost, along with CBRE Capital Markets Executive Managing Director Levy discuss their best ideas, current outlook and viewpoints on all things in the commercial real estate sector on an Analyst/Industry conference call to be held on September 19 at 11 am.
09:59 EDTMSFT, ANFGYOn The Fly: Analyst Upgrade Summary
Subscribe for More Information
09:40 EDTSTMSTMicroelectronics, AT&S, Soundchip announce collaboration
Subscribe for More Information
09:07 EDTMSFTMicrosoft to launch Microsoft Dynamics CRM 2015 in Q4
Microsoft on Tuesday announced that Microsoft Dynamics CRM 2015, as well as updates to its Microsoft Dynamics CRM Online and Microsoft Dynamics Marketing services, will be generally available in the Q4.
08:07 EDTMDTMedtronic drug-coated baloon shows strong clinical, economic benefit
Presented for the first time at the 2014 Transcatheter Cardiovascular Therapeutics, or TCT, conference, the latest clinical and economic data on the IN.PACT Admiral drug-coated balloon, or DCB, from Medtronic augments an already robust body of evidence that continues to drive a reconsideration of the standard of care for peripheral artery disease, or PAD, in leg arteries above the knee. The IN.PACT Admiral DCB remains an investigational medical device in the United States. No drug-coated balloon has yet received approval from the FDA. The new data come from the real-world IN.PACT Global study, the largest and most rigorous post-market evaluation of its kind for any peripheral artery intervention, and from an ongoing economic outcomes analysis of the U.S. phase of the landmark IN.PACT SFA trial. Together, the results show that the IN.PACT Admiral DCB is not only clinically superior, but also cost-effective for the treatment of atherosclerotic lesions in the superficial femoral artery, or SFA, or proximal popliteal artery, or PPA, at 12 months compared to standard percutaneous transluminal angioplasty, or PTA.
07:57 EDTMSFTFBN Securities to hold a tour
Subscribe for More Information
07:31 EDTJNJ, MDTEuropean Association for Study of Diabetes to hold annual meeting
50th Annual Meeting of EASD to be held in Vienna, Austria on September 15-19.
07:19 EDTMSFTCompanies' share buybacks at fasttest clip since 2007, WSJ reports
Companies are buying back their own shares at its fastest pace since the financial crisis to fuel a stock rally, reports the Wall Street Journal. According to Birinyi Associates, companies have bought back $338.3B of stock in 1H14, the most since 2007. Citing an analysis by Barclays, companies with the largest buyback programs by dollar value have outperformed the broader market by 20% since 2008. Reference Link
05:41 EDTSTMSTMicroelectronics to sell certain products to MegaChips
MegaChips Technology America announced that following the signature of an agreement with STMicroelectronics (STM, ST) and final closing on September 2, it has acquired 9 smart connectivity products based on DisplayPort technology that ST decided to discontinue last year, along with its related assets, business and products in development. During the transition, ST and MegaChips ensured continuity of products and services to customers. A number of employees engaged in product development and marketing in relation to the acquired business from ST, joined MegaChips America. This group included Mr. Alan Kobayashi, currently the chair of VESA, who joined MegaChips America as a Fellow and Product Development Manager.
05:27 EDTANFGYAntofagasta upgraded to Hold from Sell at Deutsche Bank
Subscribe for More Information
1 | 2 | 3 | 4 | 5 | all recent news | >>

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use